Liability for sale of future royalties - long term
133,552
136,561
136,985
136,913
Financing liability - long term
92,497
92,784
93,092
93,310
Deferred revenue long term
36,857
38,905
39,977
48,194
Recognized loss on purchase commitments long term
62,922
64,635
65,952
65,956
Operating lease liability
9,687
10,281
10,689
10,258
Contingent consideration - long term
-
5,146
5,114
-
Milestone liabilities
2,003
2,003
2,003
2,003
Term loan
319,085
318,722
318,361
73,428
Total liabilities
799,501
803,598
843,204
539,192
Common stock, 0.01 par value - 800,000,000 shares authorized 309,911,682 and 307,832,587 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
3,099
3,089
3,078
3,070
Additional paid-in capital
3,161,330
3,150,295
3,141,741
3,132,249
Accumulated other comprehensive (loss) income
-19
-4
115
137
Accumulated deficit
-3,231,607
-3,212,575
-3,195,956
-3,180,008
Total stockholders' deficit
-67,197
-59,195
-51,022
-44,552
Total liabilities and stockholders' deficit
732,304
744,403
792,182
494,640
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.